These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11179963)

  • 1. Functional and structural characterization of the insertion region in the ligand binding domain of the vitamin D nuclear receptor.
    Rochel N; Tocchini-Valentini G; Egea PF; Juntunen K; Garnier JM; Vihko P; Moras D
    Eur J Biochem; 2001 Feb; 268(4):971-9. PubMed ID: 11179963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction.
    Masuyama H; Brownfield CM; St-Arnaud R; MacDonald PN
    Mol Endocrinol; 1997 Sep; 11(10):1507-17. PubMed ID: 9280066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of transcriptional activation and DNA-binding functions in the hinge region of the vitamin D receptor.
    Shaffer PL; McDonnell DP; Gewirth DT
    Biochemistry; 2005 Feb; 44(7):2678-85. PubMed ID: 15709781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular modeling, affinity labeling, and site-directed mutagenesis define the key points of interaction between the ligand-binding domain of the vitamin D nuclear receptor and 1 alpha,25-dihydroxyvitamin D3.
    Swamy N; Xu W; Paz N; Hsieh JC; Haussler MR; Maalouf GJ; Mohr SC; Ray R
    Biochemistry; 2000 Oct; 39(40):12162-71. PubMed ID: 11015194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D receptors from patients with resistance to 1,25-dihydroxyvitamin D3: point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner.
    Whitfield GK; Selznick SH; Haussler CA; Hsieh JC; Galligan MA; Jurutka PW; Thompson PD; Lee SM; Zerwekh JE; Haussler MR
    Mol Endocrinol; 1996 Dec; 10(12):1617-31. PubMed ID: 8961271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand.
    Rochel N; Wurtz JM; Mitschler A; Klaholz B; Moras D
    Mol Cell; 2000 Jan; 5(1):173-9. PubMed ID: 10678179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary 1,25-dihydroxyvitamin D resistant rickets due to a mutation causing multiple defects in vitamin D receptor function.
    Malloy PJ; Xu R; Peng L; Peleg S; Al-Ashwal A; Feldman D
    Endocrinology; 2004 Nov; 145(11):5106-14. PubMed ID: 15308610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A unique insertion/substitution in helix H1 of the vitamin D receptor ligand binding domain in a patient with hereditary 1,25-dihydroxyvitamin D-resistant rickets.
    Malloy PJ; Xu R; Cattani A; Reyes mL; Feldman D
    J Bone Miner Res; 2004 Jun; 19(6):1018-24. PubMed ID: 15190891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
    Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
    J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A highly conserved region in the hormone-binding domain of the human vitamin D receptor contains residues vital for heterodimerization with retinoid X receptor and for transcriptional activation.
    Whitfield GK; Hsieh JC; Nakajima S; MacDonald PN; Thompson PD; Jurutka PW; Haussler CA; Haussler MR
    Mol Endocrinol; 1995 Sep; 9(9):1166-79. PubMed ID: 7491109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characterization of ligand-dependent transactivation regions of the human vitamin D receptor].
    Nakajima S
    Nihon Rinsho; 1998 Jul; 56(7):1717-21. PubMed ID: 9702043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-specific structural changes in the vitamin D receptor in solution.
    Singarapu KK; Zhu J; Tonelli M; Rao H; Assadi-Porter FM; Westler WM; DeLuca HF; Markley JL
    Biochemistry; 2011 Dec; 50(51):11025-33. PubMed ID: 22112050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand recognition by the vitamin D receptor.
    Choi M; Yamamoto K; Masuno H; Nakashima K; Taga T; Yamada S
    Bioorg Med Chem; 2001 Jul; 9(7):1721-30. PubMed ID: 11425573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural investigation of the ligand binding domain of the zebrafish VDR in complexes with 1alpha,25(OH)2D3 and Gemini: purification, crystallization and preliminary X-ray diffraction analysis.
    Ciesielski F; Rochel N; Mitschler A; Kouzmenko A; Moras D
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):55-9. PubMed ID: 15225747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M; Freedman LP; Li H; Christakos S
    Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of the human vitamin D receptor by caspase-3.
    Malloy PJ; Feldman D
    Endocrinology; 2009 Feb; 150(2):679-86. PubMed ID: 18832097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine tuning of agonistic/antagonistic activity for vitamin D receptor by 22-alkyl chain length of ligands: 22S-Hexyl compound unexpectedly restored agonistic activity.
    Anami Y; Sakamaki Y; Itoh T; Inaba Y; Nakabayashi M; Ikura T; Ito N; Yamamoto K
    Bioorg Med Chem; 2015 Nov; 23(22):7274-81. PubMed ID: 26515040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel inborn error in the ligand-binding domain of the vitamin D receptor causes hereditary vitamin D-resistant rickets.
    Malloy PJ; Zhu W; Zhao XY; Pehling GB; Feldman D
    Mol Genet Metab; 2001 Jun; 73(2):138-48. PubMed ID: 11386849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-function analysis of vitamin D and VDR model.
    Yamada S; Yamamoto K; Masuno H
    Curr Pharm Des; 2000 May; 6(7):733-48. PubMed ID: 10828304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.